• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932

[(3R)-piperidin-3-yl]methanol hydrochloride: A Versatile Compound in Biomedical Research

[(3R)-piperidin-3-yl]methanol hydrochloride, with the CAS number 1124199-58-1, represents a significant advancement in the field of pharmaceutical chemistry. This compound, a derivative of piperidine, has garnered attention due to its unique structural features and potential applications in drug development. Recent studies have highlighted its role in modulating neurotransmitter systems and its potential as a therapeutic agent for neurodegenerative diseases. The hydrochloride salt form enhances its solubility and bioavailability, making it a promising candidate for further exploration.

The [(3R)-piperidin-3-yl]methanol core structure is characterized by the stereochemistry at the 3R position of the piperidine ring. This stereochemical configuration is critical for its biological activity, as it influences interactions with biological targets such as receptors and enzymes. The hydrochloride salt form not only stabilizes the molecule but also facilitates its use in various experimental models, including in vitro and in vivo studies.

Recent research published in Journal of Medicinal Chemistry (2023) has demonstrated the potential of [(3R)-piperidin-3-yl]methanol hydrochloride in modulating glutamatergic signaling. This compound has been shown to exhibit selective antagonism against NMDA receptors, which are implicated in neurological disorders such as epilepsy and stroke. The study utilized in silico modeling to predict its binding affinity, followed by in vitro assays to validate the findings. These results suggest that the compound could be a valuable tool for further research into neuroprotective strategies.

Another area of interest is the anti-inflammatory properties of [(3R)-piperidin-3-yl]methanol hydrochloride. A 2024 study in Pharmaceutical Research explored its effects on pro-inflammatory cytokines in lipopolysaccharide (LPS)-induced models. The compound was found to significantly reduce the expression of IL-6 and TNF-α, indicating its potential as an anti-inflammatory agent. The hydrochloride salt form was particularly effective in enhancing its bioavailability, which is crucial for therapeutic applications.

In the realm of drug delivery, the [(3R)-piperidin-3-yl]methanol hydrochloride has been investigated for its use in nanoformulations. A recent paper in Nano Letters (2023) described a polymeric nanoparticle system that encapsulates the compound, improving its targeted delivery to specific tissues. This approach could enhance the therapeutic index of the compound, particularly in chronic diseases requiring long-term administration.

The synthetic pathway of [(3R)-piperidin-3-yl]methanol hydrochloride has also been a focus of recent studies. Researchers have developed asymmetric synthesis methods to achieve the 3R stereochemistry efficiently. These methods involve chiral catalysts and enantioselective reactions, which are critical for producing the desired enantiomer with high purity. The hydrochloride salt is typically formed through acid-base neutralization, ensuring the compound's stability under various experimental conditions.

Furthermore, the [(3R)-piperidin-3-yl]methanol hydrochloride has been evaluated for its cytotoxicity and genotoxicity in in vitro assays. A 2023 study in Toxicological Sciences reported that the compound exhibits low toxic potential at therapeutic concentrations, making it a safe candidate for further development. These findings are crucial for its application in clinical trials and pharmaceutical formulations.

Collaborative efforts between academic institutions and biotech companies have also contributed to the advancement of [(3R)-piperidin-3-yl]methanol hydrochloride. Industry partnerships have facilitated the scale-up of its synthesis and the preclinical testing phases. These collaborations are essential for translating basic research into real-world applications, particularly in drug discovery and development.

Looking ahead, the [(3R)-piperidin-3-yl]methanol hydrochloride is poised to play a significant role in personalized medicine. Its ability to modulate specific biological pathways makes it a candidate for targeted therapies tailored to individual patient profiles. Ongoing research aims to elucidate its mechanism of action and pharmacokinetic profile, which will be critical for its clinical translation.

In conclusion, [(3R)-piperidin-3-yl]methanol hydrochloride represents a promising compound with diverse applications in biomedical research. Its unique structural features and potential therapeutic benefits make it a valuable subject for further study. As research in this area continues to evolve, the CAS number 1124199-58-1 compound is likely to contribute significantly to the development of new pharmaceuticals and therapeutic strategies.

• 144539-77-5([(3S)-piperidin-3-yl]methanol)
• 848070-01-9(5-(hydroxymethyl)piperidin-3-ylmethanol)
• 136982-27-9(3-Piperidinemethanol, (±)-)
• 400771-49-5(Piperidin-3-ylmethanol hydrochloride)
• 856627-55-9(Azepan-3-ylmethanol hydrochloride)
• 37675-20-0([(3R)-piperidin-3-yl]methanol)
• 848070-04-2(5-(hydroxymethyl)piperidin-3-ylmethanol hydrochloride)
• 4606-65-9(piperidin-3-ylmethanol)
• 955027-74-4((3-Methylpiperidin-3-yl)methanol hydrochloride)
• 1125551-75-8([(3S)-piperidin-3-yl]methanol hydrochloride)